ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.

March 26, 2004

NTP Board Okays Contract Concepts

July 10, 1981

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

Coffin, McIntosh Named Cancer Society Research Professors

February 11, 1994

Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws

November 20, 1992

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001